Infections
|
March 13, 2025

Blastomycosis: Causes & Symptoms

Written By
Medically Reviewed by
Updated On
April 2, 2025

Persistent cough, chest pain, and fatigue can disrupt daily life, leaving you feeling drained and concerned. Thousands of people experience these symptoms each year due to blastomycosis, a fungal infection often mistaken for more common illnesses like pneumonia. 

This article explains the causes, symptoms, and diagnosis of blastomycosis and provides essential tips on treatment and prevention.

[signup]

What's Blastomycosis?

Blastomycosis is a fungal infection caused by Blastomyces dermatitidis. It is found in moist soil near rivers, lakes, and wooded areas. When disturbed, its spores become airborne and can be inhaled, mainly affecting the lungs.

Inside the body, the spores turn into yeast and can spread to the skin, bones, and nervous system. Symptoms range from mild to severe and can be acute or chronic. It is often mistaken for pneumonia or tuberculosis, making diagnosis difficult. People with weakened immune systems are at higher risk, but healthy individuals can also be affected.

Overview of Blastomyces dermatitidis

Blastomyces dermatitidis is a dimorphic fungus that exists as mold in the environment and as yeast in the body. When soil is disturbed, its spores become airborne and can be inhaled, transforming into yeast that multiplies and spreads in the body.

The fungus thrives in moist soil with decaying wood and leaves, mainly around the Ohio and Mississippi River valleys, the Great Lakes, and parts of Canada. It can also affect travelers and outdoor enthusiasts in these areas.

History and Epidemiology

Blastomycosis was first identified in 1894 by Dr. Thomas Gilchrist, who discovered its fungal cause after observing unusual skin lesions in a patient. This led to the recognition of blastomycosis as a distinct medical condition.

The infection is most common in North America, especially near the Ohio and Mississippi River valleys, the Great Lakes, and parts of Canada. Smaller pockets have been reported in Africa and India. 

The Centers for Disease Control and Prevention (CDC) estimates 1-2 cases per 100,000 people annually in endemic areas, although the actual number may be higher due to underdiagnosis. Blastomycosis mostly affects people who spend time outdoors, such as hunters, campers, and construction workers, but urban cases have also been reported.

Causes and Transmission

Blastomyces dermatitidis is a dimorphic fungus, meaning it can exist as mold in the environment and as yeast in the body. In soil, it grows as mold and produces lightweight spores that become airborne when the soil is disturbed.

When inhaled, the spores transform into yeast, which can multiply in the lungs. If the immune system doesn’t contain it, the yeast may spread through the bloodstream to the skin, bones, and nervous system, causing various symptoms. Its ability to switch forms helps it survive in both the environment and the human body, increasing its potential to cause infection.

Environmental Reservoirs and Habitats

Blastomyces dermatitidis is commonly found in moist soil rich in decaying organic matter, such as:

  • Forests and wooded areas
  • Riverbanks and lakeshores
  • Farms and agricultural lands
  • Areas with decomposing leaves, wood, or animal droppings

Regions near the Ohio and Mississippi River valleys, the Great Lakes, and certain parts of Canada are known hotspots for this fungus. However, it has also been found in Africa and India. The fungus thrives in these environments because of the high humidity and organic material that supports its growth as a mold.

People engaging in outdoor activities in these areas, such as hunting, camping, or gardening, are more likely to encounter the spores.

Transmission Pathways

Blastomycosis occurs when a person breathes in spores from the environment. The tiny spores are too small to be seen with the naked eye, making it easy to inhale them without knowing. Once inhaled, the spores reach the lungs, where they transform into yeast and begin to multiply.

In most cases, the body’s immune system can contain the infection in the lungs. However, if the immune system is weakened or if many spores are inhaled, the yeast can spread through the bloodstream to other organs, leading to more severe symptoms.

It’s important to note that blastomycosis is not contagious. It cannot spread from person to person, or from animals to humans. The only way to get infected is by inhaling spores from the environment.

Risk Factors for Infection

While anyone can get blastomycosis, certain factors increase the risk:

  • Geographic Location: People living in or visiting endemic areas, such as the Ohio and Mississippi River valleys or the Great Lakes region, are at higher risk.
  • Outdoor Activities: Activities that disturb the soil, such as camping, hunting, construction, gardening, and hiking, can release spores into the air.
  • Occupation: Jobs involving soil excavation, farming, or construction increase the likelihood of exposure.
  • Weakened Immune System: Individuals with weakened immune systems, such as those with HIV/AIDS, cancer, or organ transplants, are more likely to develop severe infections.
  • Pets: Dogs are particularly susceptible to blastomycosis, and while they can’t transmit it to humans, they can indicate environmental exposure.

Symptoms and Diagnosis

Blastomycosis symptoms can vary widely, ranging from mild to severe, and can affect different parts of the body. Some people may not show symptoms immediately, while others can develop symptoms weeks to months after exposure. The infection commonly starts in the lungs but can spread to other areas if untreated.

Early Signs and Respiratory Symptoms

The initial symptoms of blastomycosis often resemble those of the flu or pneumonia, making it easy to misdiagnose. Early signs include:

  • Fever
  • Chills
  • Cough (sometimes with mucus or blood)
  • Chest pain
  • Shortness of breath
  • Fatigue
  • Muscle pain 
  • Joint pain

These respiratory symptoms occur because the inhaled spores first infect the lungs. In some cases, mild symptoms may resolve on their own, while others may progress to more severe forms, such as pneumonia or acute respiratory distress syndrome (ARDS), requiring urgent treatment.

Skin and Bone Manifestations

If the infection spreads beyond the lungs, it can affect other organs, most commonly the skin and bones. Symptoms include:

  • Skin Lesions: Raised, warty sores that may look like ulcers. They may be painless or cause discomfort and are often mistaken for skin cancer or infections.
  • Bone and Joint Pain: Pain, swelling, or redness over bones or joints, which may indicate the spread of the fungus to the skeletal system.
  • Other Organ Involvement: In rare cases, the fungus can affect the central nervous system, leading to headaches, confusion, or seizures.

Because these symptoms can mimic other conditions, it’s important to seek medical evaluation for accurate diagnosis and appropriate treatment.

Diagnostic Methods

Proper diagnosis of blastomycosis is crucial to ensure the right treatment. Because it is similar to other respiratory illnesses, multiple tests are usually needed to confirm the infection.

Laboratory Tests and Imaging

To diagnose blastomycosis, doctors use laboratory tests and imaging to confirm the presence of Blastomyces dermatitidis and assess the severity of the infection.

Microscopic examination and culture involve analyzing samples to detect the fungus:

  • Sputum Sample: Mucus from the lungs is examined under a microscope to identify the yeast form of the fungus.
  • Tissue Biopsy: If skin lesions or bone involvement are present, a tissue sample is taken for culture and microscopic analysis.
  • Urine Antigen Test: This non-invasive test detects fungal antigens in urine and is useful when lung samples are difficult to obtain.

Imaging studies provide a clearer view of lung involvement:

  • Chest X-ray: Can show lung abnormalities like nodules or pneumonia-like patterns, but these findings are non-specific and can resemble other lung diseases.
  • CT Scan: This provides detailed images to evaluate the extent of lung infection and check for its spread to other areas.

Differential Diagnosis with Similar Conditions

Blastomycosis shares symptoms with many other respiratory and systemic diseases, making it challenging to diagnose without specific testing. Conditions that may be confused with blastomycosis include:

  • Pneumonia: Caused by bacteria or viruses with similar respiratory symptoms.
  • Tuberculosis (TB): Both can cause chronic cough, fever, and weight loss.
  • Lung Cancer: Persistent cough, chest pain, and skin lesions can mimic metastatic lung cancer.
  • Other Fungal Infections: Histoplasmosis, coccidioidomycosis, and cryptococcosis have overlapping symptoms and geographic distribution.
  • Autoimmune Diseases: Conditions like sarcoidosis and lupus can cause similar skin lesions and lung involvement.

Accurate diagnosis involves ruling out these conditions through a combination of clinical evaluation, laboratory tests, and imaging studies.

Treatment and Management

Blastomycosis is treated with antifungal medications. Healthcare providers select treatment based on the severity of the infection and the patient’s overall health. Early treatment helps prevent complications.

Antifungal Medications Used

  • Itraconazole: First-line anti-fungal medication commonly prescribed for mild to moderate cases. Taken orally for 6-12 months. Itraconazole is a first-line antifungal medication commonly prescribed for mild to moderate cases.
  • Amphotericin B: Used for severe infections, especially if vital organs are affected, and given intravenously in hospitals.
  • Fluconazole and Voriconazole: Alternatives for central nervous system involvement or if other medications are not tolerated.

Treatment Protocols

  • Mild to Moderate Cases: Oral itraconazole for 6-12 months.
  • Severe or Disseminated Cases: Start with IV amphotericin B, then switch to itraconazole.
  • CNS Involvement: High-dose amphotericin B, followed by fluconazole or voriconazole.
  • Immunocompromised Patients: More aggressive treatment and possible long-term maintenance therapy.

Patients should discuss treatment duration and possible side effects with their healthcare provider.

Managing Complications

Blastomycosis can become chronic or relapse if not fully treated. Ongoing care is needed to manage these complications.

Addressing Chronic Blastomycosis

  • Extended Therapy: Longer or combination antifungal treatments may be required.
  • Regular Monitoring: Follow-up appointments and imaging tests track recovery and detect recurrence.

Preventing Relapse

  • Complete Medication Course: Finish all prescribed doses.
  • Follow-Up Visits: Regular check-ups and tests to monitor for relapse.
  • Avoid High-Risk Environments: Until fully recovered, avoid areas where the fungus thrives, like wooded or moist soil areas.

Prevention and Public Health

To lower your risk of blastomycosis, avoid disturbing soil in wooded areas, riverbanks, or construction sites in endemic regions. Wear masks and gloves for protection if you must work in these areas. Keep pets from digging in moist soil to prevent spores from entering your home.

Stay informed about blastomycosis hotspots, especially if you live in or visit affected areas. Reporting suspected cases to health authorities helps track outbreaks. If you experience unexplained respiratory symptoms after exposure, seek medical attention promptly.

These steps can help protect you and your community from blastomycosis.

Living with Blastomycosis

Managing blastomycosis involves following your treatment plan and attending regular check-ups to monitor recovery and prevent relapse. Support your immune system by eating well and getting enough rest.

Living with a chronic illness can be emotionally challenging. While medical management is key, support groups and counseling may help individuals cope with the emotional aspects of chronic illness.

This content is for informational purposes only and should not replace professional medical advice.

[signup]

Key Takeaways

  • Blastomycosis is a fungal infection caused by inhaling spores from Blastomyces dermatitidis, which is typically found in moist soils near rivers and lakes. It primarily affects the lungs but can spread to the skin, bones, and nervous system.
  • Symptoms often resemble pneumonia or flu, including cough, fever, chest pain, and fatigue. This can lead to misdiagnosis, especially in people with weakened immune systems or those exposed to high-risk environments.
  • Effective treatment involves antifungal medications like itraconazole for mild to moderate cases and amphotericin B for severe infections, with early diagnosis and prolonged therapy being crucial to prevent complications or relapse.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Ariano, R. E., Mitchelmore, B. R., Lagacé-Wiens, P. R., & Zelenitsky, S. A. (2013). Successful treatment of pulmonary blastomycosis with continuously infused amphotericin B deoxycholate after failure with liposomal amphotericin B. The Annals of Pharmacotherapy, 47(6), e26. https://doi.org/10.1345/aph.1R703

Benedict, K., Roy, M., Chiller, T., & Davis, J. P. (2012). Epidemiologic and Ecologic Features of Blastomycosis: A Review. Current Fungal Infection Reports, 6(4), 327–335. https://doi.org/10.1007/s12281-012-0110-1

Blastomyces Dermatitidis - an overview | ScienceDirect Topics. (n.d.). Www.sciencedirect.com. https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/blastomyces-dermatitidis

Blastomycosis (Gilchrist’s disease): Symptoms & Treatment. (2024, October 30). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/blastomycosis

Bradsher, R. W. (2014). The Endemic Mimic: Blastomycosis An Illness Often Misdiagnosed. Transactions of the American Clinical and Climatological Association, 125, 188. https://pmc.ncbi.nlm.nih.gov/articles/PMC4112704/

Brick, K. E., & Agger, W. A. (2011). Successful Treatment of Brainstem Blastomycosis with Fluconazole. Clinical Medicine & Research, 10(2), 72–74. https://doi.org/10.3121/cmr.2011.1023

CDC. (2024a, April 23). Data and Statistics on Blastomycosis. Blastomycosis. https://www.cdc.gov/blastomycosis/data-research/statistics/index.html

CDC. (2024b, April 23). Symptoms of Blastomycosis. Blastomycosis. https://www.cdc.gov/blastomycosis/signs-symptoms/index.html

CDC. (2024c, May 9). Blastomycosis Basics. Blastomycosis. https://www.cdc.gov/blastomycosis/about/index.html

CDC. (2024d, May 14). Blastomycosis. Blastomycosis. https://www.cdc.gov/blastomycosis/index.html

Chapman, S. W., Bradsher, R. W., Campbell, G. D., Pappas, P. G., & Kauffman, C. A. (2000). Practice Guidelines for the Management of Patients with Blastomycosis. Clinical Infectious Diseases, 30(4), 679–683. https://doi.org/10.1086/313750

Chen, S. C. A., & Sorrell, T. C. (2007). Antifungal agents. Medical Journal of Australia, 187(7), 404–409. https://doi.org/10.5694/j.1326-5377.2007.tb01313.x

Choptiany, M., Wiebe, L., Limerick, B., Sarsfield, P., Cheang, M., Light, B., Hammond, G., MacDonald, K., Trepman, E., Pappas, P., & Embil, J. M. (2009). Risk Factors for Acquisition of Endemic Blastomycosis. Canadian Journal of Infectious Diseases and Medical Microbiology, 20(4), 117–121. https://doi.org/10.1155/2009/824101

Cloyd, J. (2023, March 7). An integrative medicine approach to fatigue. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-fatigue

Cloyd, J. (2025, February 7). Addressing Lingering Cough. Rupa Health. https://www.rupahealth.com/post/addressing-lingering-cough

Durkin, M., Witt, J., LeMonte, A., Wheat, B., & Connolly, P. (2004). Antigen Assay with the Potential To Aid in Diagnosis of Blastomycosis. Journal of Clinical Microbiology, 42(10), 4873–4875. https://doi.org/10.1128/jcm.42.10.4873-4875.2004

Henry, R. (2014). Etymologia: Blastomycosis. Emerging Infectious Diseases, 20(11), 1794–1794. https://doi.org/10.3201/eid2011.et2011

Khadilkar, A., Waddell, L., Acheson, E. S., & Ogden, N. H. (2024). Perspectives on blastomycosis in Canada in the face of climate change. Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada, 50(11), 400–411. https://doi.org/10.14745/ccdr.v50i11a04

Kumar, A., Kunoor, A., Eapen, M., Singh, P. K., & Chowdhary, A. (2019). Blastomycosis Misdiagnosed as Tuberculosis, India. Emerging Infectious Diseases, 25(9), 1776–1777. https://doi.org/10.3201/eid2509.190587

Martynowicz, M. A., & Prakash, U. B. S. (2002). Pulmonary Blastomycosis. Chest, 121(3), 768–773. https://doi.org/10.1378/chest.121.3.768

McBride, J. A., Gauthier, G. M., & Klein, B. S. (2017). Clinical Manifestations and Treatment of Blastomycosis. Clinics in Chest Medicine, 38(3), 435–449. https://doi.org/10.1016/j.ccm.2017.04.006

Meece, J., Anderson, J., Klein, B., Sullivan, T., Foley, S., Baumgardner, D., Brummitt, C., & Reed, K. (2009). Genetic diversity in Blastomyces dermatitidis: implications for PCR detection in clinical and environmental samples. Medical Mycology, 1–7. https://doi.org/10.1080/13693780903103952

Miceli, A., & Krishnamurthy, K. (2020). Blastomycosis. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK441987/

Oppenheimer, M., Embil, J. M., Black, B., Wiebe, L., Limerick, B., MacDonald, K., & Trepman, E. (2007). Blastomycosis of Bones and Joints. Southern Medical Journal, 100(6), 570–578. https://doi.org/10.1097/smj.0b013e3180487a92

Owen, W. R., Thurs, K., & Kim, D. S. L. (2012). Blastomycosis Presenting as a Nonhealing Wound. Advances in Skin & Wound Care, 25(7), 321–323. https://doi.org/10.1097/01.asw.0000416005.78089.b0

Patel, A. J., Gattuso, P., & Reddy, V. B. (2010). Diagnosis of Blastomycosis in Surgical Pathology and Cytopathology: Correlation With Microbiologic Culture. The American Journal of Surgical Pathology, 34(2), 256–261. https://doi.org/10.1097/pas.0b013e3181ca48a5

Preston, J. (2023, December 18). Functional Medicine Strategies for Managing Joint Pain in Cold Weather. Rupa Health. https://www.rupahealth.com/post/functional-medicine-strategies-for-managing-joint-pain-in-cold-weather

Pullen, M. F., Alpern, J. D., & Bahr, N. C. (2022). Blastomycosis—Some Progress but Still Much to Learn. Journal of Fungi, 8(8), 824. https://doi.org/10.3390/jof8080824

Ronald, S., Strzelczyk, J., Moore, S., Trepman, E., Cheang, M., Limerick, B., Wiebe, L., Sarsfield, P., Macdonald, K., Meyers, M., & Embil, J. M. (2009). Computed tomographic scan evaluation of pulmonary blastomycosis. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses et de La Microbiologie Medicale, 20(4), 112–116. https://doi.org/10.1155/2009/763018

Schwartz, I. S. (2017). Blastomycosis in Mammals. Emerging and Epizootic Fungal Infections in Animals, 159–176. https://doi.org/10.1007/978-3-319-72093-7_8

Schwartz, I. S., Muñoz, J. F., Kenyon, C. R., Govender, N. P., McTaggart, L. R., Maphanga, T. G., Richardson, S. E., Becker, P., Cuomo, C. A., McEwen, J. G., & Sigler, L. (2020). Blastomycosis in Africa and the Middle East: A Comprehensive Review of Reported Cases and Reanalysis of Historical Isolates Based on Molecular Data. Clinical Infectious Diseases, 73(7), e1560–e1569. https://doi.org/10.1093/cid/ciaa1100

Shaffer, A., Johnson, R., Guglielmi, G., Naik, A., Najafali, D., Khan, A. A., Bellafiore, F. J., Arnold, P. M., & Wael Hassaneen. (2023). Disseminated blastomycosis with an intracranial fungoma in an immunocompetent patient: illustrative case. Journal of Neurosurgery Case Lessons, 5(3). https://doi.org/10.3171/case22406

Wilson, E. (2024, December 19). Low-Grade Fever: Causes, Symptoms, and Management. Rupa Health. https://www.rupahealth.com/post/low-grade-fever-causes-symptoms-and-management

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Infections
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.